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Abstract 
There are conflicting prevalence estimates of autism spectrum disorders (ASDs) in mainland China 
(China thereafter). This study is a comprehensive meta-analysis of the pooled prevalence of ASDs in 
the general population in China. Study investigators independently conducted a systematic literature 
search of the following databases: PubMed, EMBASE, PsycINFO, China National Knowledge 
Infrastructure, Chinese biomedical literature service system, and Wan Fang. Studies reporting 
prevalence of ASDs and autism in Chinese population were identified and analysed using the 
Comprehensive Meta-Analysis program with the random effects model. Forty-four studies were 
included in the meta-analysis comprising 2,337,321 subjects of whom 46.66 % were females. The 
mean age of subjects ranged from 1.6 to 8 years. Based on diagnostic criteria the pooled prevalence 
of ASDs was 39.23 per 10,000 (95% CI: 28.44-50.03 per 10,000, I2=89.2%); specifically, the 
prevalence of autism was 10.18 per 10,000 (95% CI: 8.46-11.89 per 10,000, I2=92.5%). Subgroup 
analyses revealed significant difference in the prevalence of ASDs between genders (72.77 per 
10,000 in males vs. 16.45 per 10,000 in females). In conclusion, the prevalence of ASDs and autism 
in China was found generally lower than those reported in other countries. Further studies are 
needed to clarify the variation in prevalence. 
Key words: Autism spectrum disorder, prevalence, meta-analysis, China 
Introduction 
Autism spectrum disorders (ASDs) refer to a 
group of pervasive developmental disorders caused 
by a combination of genetic and environmental 
factors. They are often associated with pronounced 
personal suffering and heavy burden of care to 
families and society [1]. ASDs consist of several 
subtypes, with autism being the core and the most 
common one. ASDs usually occur in infancy [2] and 
present with complex symptoms. Children with ASDs 
usually have difficulties in understanding language 
and social behaviors; parental concern is often 
centered around their children presenting abnormal 
behaviors, such as mutism, echolalia and lack of 
expressive emotion [3]. 
Accurate estimation of the prevalence of ASDs is 
important for the health sectors to understand its 
impact on the general population and provide 
appropriate resource allocations. A number of 
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epidemiological studies have found an increasing 
trend in prevalence of ASDs, for example, in the 1990s 
the prevalence rate of ASDs were 4-5 per 10,000 in the 
USA, as compared to 113 per 10,000 in 2008 [4]. The 
apparent growing trend could be partly explained by 
the discrepancy in age of subjects, diagnostic criteria 
and sampling methods [5]. In addition, there is wide 
variation in the prevalence of ASDs between 
countries. For instance, the prevalence of autism was 
34 per 10,000 in USA [6] versus 99 per 10,000 in the 
UK [7]. A review of 23 studies found that the 
estimated prevalence of ASDs across Asia countries/ 
territories (China, Japan, Israel, Iran, Taiwan and 
Indonesia) varied from 1.1 to 21.8 per 10,000 [8].  
In China, prevalence studies of ASDs have 
shown conflicting findings. Moreover, most studies 
were published in Chinese-language journals that are 
not accessible to international readership. A review of 
24 studies [9] found that the pooled prevalence of 
ASDs in Chinese children was 24.5 per 10,000. 
Another meta-analysis of 18 studies in China [10] 
found that a pooled prevalence of autism of 11.8 per 
10,000. More than 20 ASDs prevalence studies have 
been recently published in Chinese, which have 
enhanced the epidemiological dataset, but are 
generally not accessible to the international 
readership. Therefore, we set out to conduct this 
comprehensive meta-analysis of the pooled 
prevalence of ASDs in China and also to examine its 
mediating factors (e.g., gender, region, study period, 
and diagnostic tools used). 
Methods 
Search strategy and selection criteria 
The literature search process is shown in Figure 
1. Two investigators (WF and LL) independently 
searched the literature using PubMed, EMBASE, 
PsycINFO, China National Knowledge Infrastructure, 
Chinese biomedical literature service system 
(SinoMed) and Wan Fang, from their inception to 
February 1st 2017. Search terms included (‘autism’ or 
‘autistic disorder’ or ‘autism spectrum conditions’ or 
‘pervasive developmental disorders’ or ‘Asperger’) 
and (‘epidemiology’ or ‘cross-sectional study’ or 
‘prevalence’ or ‘rate’) and (‘China’ or ‘Chinese’). In 
order to avoid missing any studies, the reference lists 
of relevant review or meta-analyses were searched 
manually. If more than one publication was reported 
based on the same dataset, only the paper with 
complete data was included.  
Inclusion criteria were as follows: 1) 
cross-sectional or cohort studies 
conducted in mainland China (China 
thereafter) (only baseline data were 
extracted in the latter); 2) participants aged 
≤18 years; 3) the diagnosis of ASD was 
established by either clinical diagnostic 
criteria [such as the Diagnostic and 
Statistical Manual of Mental Disorder 
(DSM), Chinese Classification of Mental 
Disorder (CCMD) or International 
Classification of Disease (ICD) systems], or 
screening tools [such as the Clancy Autism 
Behavior Scale (CABS), Children Autism 
Spectrum Test (CAST) and Checklist for 
Autism in Toddlers (CHAT)]. Both clinical 
diagnostic criteria and screening tools on 
ASDs and autism were involved because 
they have been widely used in 
epidemiology and clinical practice in 
China.  
Studies selection and data extraction 
After removing the duplicates, two 
investigators (WF and LL) independently 
screened the titles and abstracts of all 
records, and then selected the articles that 
fulfilled the inclusion criteria. Any 
uncertainties were resolved by consensus 
or with a third reviewer (WSB). 
 
 
Figure 1. Flow chart of the study 
Int. J. Biol. Sci. 2018, Vol. 14 
 
 
http://www.ijbs.com 
719 
 The same two investigators independently 
performed the data extraction using a standard data 
extraction form. Information extracted included the 
study characteristics (e.g., title, the first author, 
publication year, study site, survey time, sample 
method, sample size, response rate), ASD subtype, 
age, gender proportion, residence (urban/ rural area), 
screening and diagnostic tools, and data on the 
prevalence of ASDs and subtypes.  
Quality assessment 
Two investigators (WF and LL) independently 
assessed the quality of included studies using a 
methodological quality assessment tool with 8 items 
[11, 12]. Each study was scored from 0 to 8. The score 
of 7-8 indicated ‘high quality’, 4-6 indicated ‘modera-
ted quality’ and 0-3 indicated ‘low quality’ [12]. Any 
disagreement in the assessment process was discuss-
ed and resolved with a third investigator (WSB). 
Statistical analysis 
The Comprehensive Meta-Analysis software 
version 2 was used to synthesize the data. Due to the 
heterogeneity in sampling methods, assessment 
instruments and sample size across studies, 
random-effects model was used to estimate the 
pooled prevalence of ASD [13]. The I2 statistic was 
used to assess the degree of heterogeneity across 
included studies. Sensitivity and subgroup analysis 
were used to examine the sources of heterogeneity if 
present. Publication bias was evaluated with the 
funnel plots and Egger’s test and the significance level 
was set at 0.05 (two-sided). 
Results 
Search results and characteristics of studies 
Of 2,375 eligible papers identified in literature 
search, 44 fulfilled the inclusion criteria after 
screening the titles, abstracts and full texts, and 
removing the duplicates (Figure 1). Five of these 
studies were published in English and thirty-nine in 
Chinese. Their sample size ranged from 259 to 
1,348,030 subjects and 42 studies had a sample size 
greater than 1000. The 44 included studies had a total 
of 2,337,321 subjects of which 46.66% were females. 
Sixteen studies reported on the prevalence of ASDs, 
while 28 focused on the prevalence of autism. 
The characteristics of the included studies are 
shown in Table 1. These studies were conducted 
between 2000 and 2016 in 30 provinces/ 
municipalities/ autonomous regions in China. Mean 
age of the subjects ranged from 1.6 to 8 years, with the 
median age of 4 years. Twenty-seven studies were 
conducted in urban areas (61.4%) and the others were 
in both urban and rural areas (urban/rural were 
defined by the studies included in the meta-analysis). 
Twenty-seven studies were conducted in eastern 
China, nine in central China, seven studies in western 
China, and one study was a national survey. The 
CABS was the most commonly used screening tool 
(22/44). 
Evaluation quality of the studies  
The quality assessment scores ranged from 4 to 
8. Based on the assessment criteria, 7 studies were 
rated as ‘high quality’, and 37 was as ‘moderate 
quality’ (Table 4).  
Table 4. Quality assessment of the included studies 
Items Yes, n (%) No, n (%) Unclear, n 
(%) 
1. Is the target population clearly defined? 43 (97.7) 1 (2.27) 0 
2. Was either of the following ascertainment 
methods used [must be one or the other]? (1) 
probability sampling, or (2) entire population 
surveyed 
41 (93.2) 3 (6.82) 0 
3. Is the response rate >70% 26 (59.1) 18 (40.9) 0 
4. Are nonresponders clearly described? 2 (4.5) 42 (95.5) 0 
5. Is the sample representative of the target 
population? 
42 (95.5) 2 (4.5) 0 
6. Were data collection methods 
standardized? 
44 (100) 0 0 
7. Were validated criteria used to assess for 
the presence/absence of disease? 
44 (100) 0 0 
8. Are the estimates of prevalence given with 
confidence intervals and in detail by subgroup 
(if applicable)? 
9 (20.5) 35 (79.5) 0 
 
Prevalence of ASDs  
Prevalence of ASDs based on clinical diagnostic 
criteria 
The pooled prevalence of ASDs from 16 studies 
with available data was 39.23 per 10,000 (95% CI: 
28.44 to 50.03 per 10,000, I2=89.2%) (Figure 2A). The 
prevalence of ASDs in males (72.77 per 10,000) was 
higher than in females (16.45 per 10,000). The 
prevalence of ASDs in rural areas was higher than in 
urban areas (62.26 per 10,000 vs. 32.73 per 10,000). The 
pooled prevalence of ASDs from studies conducted in 
or before 2012 was slightly higher than that those after 
2012 (38.72 per 10,000 vs. 36.36 per 10,000) after study 
years were dichotomized using median splitting 
method. The prevalence of ASDs in eastern and 
central China was 45.81 per 10,000 and 50.85 per 
10,000, respectively. Meta-regression analysis did not 
find any association between age and prevalence of 
ASDs (p=0.784). Subgroup analyses of diagnostic 
instruments used revealed no difference between 
prevalence of ASDs established by CCMD (63.75 per 
10,000), DSM-4 (41.87 per 10,000) or DSM-5 (48.96 per 
10,000). However, one prevalence study using the 
Autism Diagnostic Observation Schedule (ADOS) 
(85.59 per 10,000) showed a higher figure than others 
(Table 2).  
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Prevalence of ASDs based on screening tools  
The pooled prevalence of ASDs from 11 studies 
with available data was 429.07 per 10,000 (95% CI: 
324.45 to 533.69 per 10,000, I2=99.5%) (Figure 3A). The 
prevalence of ASDs in males (503.53 per 10,000) was 
slightly higher than in females (294.22 per 10,000). 
Prevalence of ASDs in rural and urban was 50.03 per 
10,000 and 141.74 per 10,000, respectively. Median 
splitting method was used to dichotomize continuous 
variables in subgroup analysis. Prevalence of ASDs 
from studies conducted in and before 2012 was 
1149.51 per 10,000, while those done after 2012 was 
188.30 per 10000. The prevalence of ASDs in eastern 
China (494.32 per 10,000) was higher than central 
China (290.11 per 10,000), while no data was available 
in western China. Age was collapsed into two groups 
(≤4 years; >4 years) using median splitting method. 
The prevalence of ASDs in children aged ≤4 years 
were higher than in children > 4 years (530 per 10,000 
vs. 80 per 10,000). Eleven studies using the CABS, 
CAST, and CHAT, respectively provided different 
screening rates (422.06 per 10,000 vs. 499.29 per 10,000 
vs. 431.86 per 10,000) (Table 3). 
Table 1. Characteristic of the included studies 
Study 
 year 
First 
Author 
Ref  Region Sample  
Size 
Area* 
(urban/ 
rural) 
Age (years) Sample  Sampling 
methods 
Screening/ 
diagnostic tools 
Diagnostic  
criteria 
Autism 
events 
according 
to 
diagnostic 
criteria 
ASD 
events 
according 
to 
diagnostic 
criteria 
1996 Luo  [30] Fujian 10802 Mixed 0 to 14 G CL ABC CCMD-2-R; DSM 3 3 —— 
1999 Jiang  [31] Luoyang 10140 Mixed NA to NA PS,K R —— DSM 3 3 —— 
2000 Ren [32] Tongling 3559 Urban 3 to 5 K CL CABS —— —— —— 
2001 Zhang  [33] Guiyang 4999 Urban 0 to 6 G S; CL CABS; CARS CCMD 5 —— 
2001 Guo  [34] Tianjin 5000 Urban 0 to 6 G R CABS; CARS; PEP CCMD 5 —— 
2001 Wang  [35] Changzhou 7344 Mixed NA to NA G S; CL CABS CCMD 9 —— 
2003 Yang  [36] Zunyi 10412 Urban NA to NA PS R ABC DSM 4 6 —— 
2003 Liu  [37] Beijing 21866 Mixed 2 to 6 G S; CL CABS; CARS DSM 4 14 —— 
2003 Guo  [38] Dingxi 3770 Mixed 2 to 6 G R CABS; CARS DSM 4 3 —— 
2004 Zhang  [39] Tianjin 7345 Urban 2 to 6 G R CABS DSM 4 8 —— 
2006 Ji  [40] Nationwide 585679 Both 2 to 17 G R Disability screening 
questionnaire 
ICD10 124 —— 
2007 Su  [41] Tianjin 7904 Urban 1.5 to 3 REG S; CL CHAT; CARS DSM 4 22 —— 
2007 Zhang  [42] Wuxi 25521 Urban 1 to 6 C CL CHAT;CABS; CARS DSM 4 25 —— 
2008 Wang  [43] Meizhou 4156 Urban 2 to 6 K CL CABS —— —— —— 
2009 Pu  [44] Guizhou 3211 Urban 2 to 6 K CL CABS DSM 4 7 —— 
2009 Huang  [45] Tianjin 8000 Urban 1.5 to 3 G M CHAT DSM 4 —— 22 
2009 Zhou  [46] Shenzhen 2960 Urban 1 to 2 G R CHAT —— 9 —— 
2009 Wu  [47] Lianyungang 8532 Urban 0 to 3 C R CHAT; CARS DSM 4 9 —— 
2009 Chen  [48] Daqing 7034 Mixed 2 to 6 K, G S; CL CABS; ABC DSM4 —— 17 
2009 Liang  [49] Maoming 2485 Urban 3 to 6 K CL CABS ICD10; DSM 4 35 —— 
2009 Liu  [50] Shanghai 259 Urban 1.5 to 2 K CL CHAT DSM 4 1 2 
2009 Wang  [51] Guizhou 6111 Urban 2 to 6 K M CABS; CARS DSM 4 —— 46 
2009 Yu  [52] Haerbin 7059 Mixed 2 to 6 K S; CL CABS;ABC DSM 4 15 16 
2009 Li  [53] Tianjin 8274 Urban 1.5 to 3 REG S; CL CHAT; CARS DSM4 22 —— 
2011 Li  [54] Guiyang 1550 Urban 1.5 to 3 C CL M－CHAT; ABC DSM 4 48 —— 
2011 Wei  [55] Shenzhen 3624 Urban 1.5 to 2 C CL CHAT; CARS DSM4 7 10 
2012 Wang  [56] Lianyungang 2090 Both 1.5 to 3 C S; CL CABS DSM-V —— 24 
2012 Li  [57] Changchun 9714 Urban 0 to 6 G R ABC; CARS CCMD3 15 —— 
2012 Chen  [58] Zhuhai 4754 Both 1.5 to 3 REG R CHAT; CARS DSM4 —— 14 
2012 Yang  [59] Wuhan 8695 Urban 3 to 7 K CL CABS —— —— —— 
2012 Duan  [60] Zhengzhou 1000 NA 1.5 to 3 C CL CHAT; CARS; ABC DSM 4 —— 9 
2012 Wu  [61] Ningxia 1348030 NA 0 to 14 REG CL ABC; CARS ICD-10 419 —— 
2013 Li  [62] Shenzhen 1845 Urban 1.5 to 2 C CL CABS DSM－IV 4 —— 
2013 Wang  [63] Shantou 51968 Urban 3 to 6 REG R CABS ICD 10 139 —— 
2013 Gao  [64] Zhongshan 12804 Both 3 to 6 K S; CL CABS —— —— —— 
2013 Deng  [65] Hengyang 7041 Both 2 to 6 K CL CABS; CARS DSM 4 16 42 
2014 Wang  [66] Jiangmen 65651 Both 2 to 7 K CL CABS; ABC ABC 97 —— 
2014 Wang  [67] Zaozhuang 6634 NA 2 to 6 K S; CL CABS DSM-5 —— 44 
2014 Yang  [68] Shenzhen 15188 Urban 3.83 to 4.83 K CL ABC —— —— —— 
2014 Jiang  [69] Shanghai 9665 Urban 4 to 6 K CL CABS;ASSQ ADI-R;DSM-5 9 9 
2014 Sun  [70] Beijing 701 Urban 6 to 11 PS CL CAST ADOS;ADIR —— —— 
2014 Lu  [71] Shanghai 5704 Urban 2 to 6 K CL CABS DSM-5 —— 6 
2014 Cheng  [72] Ningbo 12123 Both 1 to 6 C S; CL CHAT; ABC DSM-IV-TR —— 14 
2015 Tian  [73] Jilin 6118 Urban 6 to 11 PS CL CAST CCMD —— 39 
* Rural/urban areas were defined by included studies. Sample screen: C, clinical service; G, general population; K, kindergarten; PS, population sample; REG, registration data; Sample method: CL, cluster; 
M, multiphase; R, random; S, stratified Screen tools: ABC, Autism Behavior Checklist; CABS, Clancy Autism Behavior Scale; CARS, Childhood Autism Rating Scale; CHAT, Checklist for Autism in 
Toddlers; M-CHAT, Modified Checklist for Autism in Toddlers; CAST, Children Autism Spectrum Test; ASSQ, high function Autism Spectrum screening questionnaire; PEP, Childhood Autism And 
Developmental Disabilities Psychological Assessment Scale (Psycho-educational Profile, PEP); Diagnostic criteria: ADI-R, Autism Diagnostic Interview-Revised; CCMD-2-R, Chinese Classification of 
Mental Disorders, 2nd edition, revised; DSM-III-R, Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, revised; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, 4th edition; 
DSM-V, Diagnostic and Statistical Manual of Mental Disorders, 5th edition; ICD-10, International Classification of Diseases, 10th revision; ASC, autism spectrum conditions; 
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Prevalence of autism 
Prevalence of autism based on clinical diagnostic criteria 
The pooled prevalence of autism from 25 studies 
with available data was 10.18 per 10,000 (95% CI: 
8.46-11.89 per 10,000, I2=92.5%) (Figure 2b). The 
prevalence of autism in males (20.50 per 10,000) was 
higher than in females (6.12 per 10,000). The 
prevalence of autism in urban areas was around 2 
folds higher than in rural areas (14.80 per 10,000 vs. 
6.06 per 10,000). The prevalence of autism from 
studies conducted after 2008 was higher than those in 
or before 2008 (20.40 per 10,000 vs. 8.18 per 10,000). 
The prevalence of autism between the eastern, 
western and central China showed some variation 
(14.62 per 10,000 vs. 6.41 per 10,000 vs. 8.68 per 
10,000). The prevalence of autism in the group of 
children aged ≤ 2.08 years (40 per 10,000) was 
significantly higher than those aged >2.08 years (20 
per 10,000). With the exception of one study reporting 
a low prevalence (2.96 per 10,000) using the DSM-3, 
there was no difference in prevalence of autism 
between other diagnostic criteria 
(14.78 per 10,000 using ABC, 10.05 per 
10,000 using CCMD, 17.03 per 10,000 
using DSM-4, and 10.14 per 10,000 
using ICD-10) (Table 2). 
Prevalence of autism based on screening 
tools  
The pooled prevalence of autism 
from 22 studies with available data 
was 252.84 per 10,000 (95% CI: 
216.1-289.57 per 10,000, I2=99.5%) 
(Figure 3B). The prevalence of autism 
in males (377.25 per 10,000) was 
higher than in females (247.89 per 
10,000). The prevalence of autism 
from studies conducted in and before 
2006 was 39.17 per 10,000, while those 
done after 2006 had increased to 
349.82 per 1000. The prevalence of 
autism in central China (334.73 per 
10,000) was higher than eastern China 
(260.11 per 10,000) and western China 
(149.78 per 10,000). The prevalence of 
autism was different between the two 
age groups (290 per 10,000 in those 
aged ≤3.58 years; 440 per 10,000 aged 
> 3.58 years). Significant difference in 
the prevalence of autism between 
different screening tools was 
observed (136.67 per 10,000 using 
ABC; 268.94 per 10,000 using CABS; 
406.73 per 10,000 using CHAT) (Table 
3). 
Sensitivity analysis and 
publication bias  
The sensitivity analyses did not 
find any individual studies that 
significantly influence the overall 
results in each diagnostic group. 
Egger’s test revealed publication bias 
for ASDs (ASDs: t=2.33, P=0.036), but 
not for autism (t=1.506, P=0.143). 
 
 
 
Figure 2. A) Forest plot of prevalence of autism spectrum disorders based on clinical diagnostic criteria. 
B) Forest plot of prevalence of autism based on clinical diagnostic criteria 
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Table 2. Subgroup analyses of prevalence of ASD and autism based on clinical diagnostic criteria  
  Number 
of studies 
N Event I2 (%) P Prevalence  
(per 10000) 
95% CI (per 10000)  
Lower  
95% CI (per 10000)  
Upper 
u-value P 
ASDs 16 87917 320 89.29 <0.001 39.23 28.44 50.03 1457.90  
Gender Male 13 41155 253 98.77 <0.001 72.77 54.16 91.39 30.343 <0.001 
Female 13 36137 50 93.98 <0.001 16.45 11.85 21.06 
Area Urban 6 35744 88 91.27 <0.001 32.73 20.52 44.95 0.216 0.642 
Rural 2 8384 26 96.5 <0.001 62.26 37.29 161.80 
Study time 2009-2012 9 44882 178 98.55 <0.001 38.72 26.49 50.94 0.689 0.406 
>2012 7 43035 136 99.24 <0.001 36.36 19.75 52.98 
Study site East of China 11 59665 191 99.16 <0.001 45.81 34.05 57.58 0.392 0.531 
West of China --- --- --- --- --- --- --- --- 
Central China 5 28252 123 98.51 <0.001  50.85 31.69 70.02 
Diagnostic 
criteria 
ADOS 1 701 6 - - 85.59 64.88 106.30 1.924 0.588 
CCMD 1 6118 39 - - 63.75 57.63 69.87 
DSM-4 10 57005 192 98.74 <0.001 41.87 30.26 53.47 
DSM-5 4 24093 83 99.52 <0.001 48.96 24.99 72.93 
            
Autism 25 2218950 987 99.975 <0.001 10.18 8.46 11.89 97232.57  
Gender Male 14 423777 360 99.69 <0.001 20.50 12.98 28.02 8.679 0.003 
Female 14 370495 119 98.80 <0.001 6.12 3.08 9.16 
Area Urban 20 304580 434 96.36 <0.001 14.80 9.87 19.72 4.105 0.043 
Rural 5 506027 147 95.45 <0.001 6.06 1.13 11.00 
Study time 1996-2008 8 657661 199 99.60 <0.001 8.18 4.36 12.00 5.113 0.024 
2009-2013 8 85530 200 94.05 <0.001 20.40 14.05 26.74 
Study site East of China 14 227497 401 99.38 <0.001 14.62 9.86 19.38 0.556 0.757 
West of China 6 1371972 488 99.94 <0.001 6.41 2.41 10.40 
Central China 2 19854 18 98.55 <0.001 8.68 3.51 20.87 
Diagnostic 
criteria  
ABC 1 65651 97 - - 14.78 13.85 15.70 4.149 0.386 
CCMD 5 37859 37 94.77 <0.001 10.05 4.52 15.57 
DSM-III 1 10140 3 - - 2.96 1.90 4.02 
DSM-IV 13 108131 150 97.33 <0.001 17.03 13.09 20.97 
ICD-10 4 1994209 691 99.95 <0.001 10.14 8.10 12.19 
Age (years) ≤2.08 5 15552 82 96.92 <0.001 40 10 140 0.976 0.323 
＞2.08 4 40208 128 8.861 <0.001 20 10 70 
Diagnosis tools: ABC, Autism Behavior Checklist; ADOS: Autism Diagnostic Observation Schedule; CCMD, Chinese Classification of Mental Disorders; DSM-III, Diagnostic and Statistical Manual of 
Mental Disorders, 3rd edition, revised; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, 4th edition; DSM-V, Diagnostic and Statistical Manual of Mental Disorders, 5th edition; ICD-10, 
International Classification of Diseases, 10th revision 
Table 3. Subgroup analyses of prevalence of ASD and autism based on screening tools 
  Number of 
studies 
N Event I2(%) P Prevalence  
(per 10000) 
95% CI  
(per 10000); Lower 
95% CI  
(per 10000); Upper 
u-value p 
ASD 11 67321 2203 99.43 <0.001 429.07  324.45 533.69 1765.58  
Gender Males 4 12223 287 99.09 <0.001 503.53 247.72 759.35 0.258 0.612 
Females 4 10842 160 98.49 <0.001 294.22 123.97 464.48 
Area Urban 4 29124 479 99.25 <0.001 141.74 50.67 232.81 0.023 0.88 
Rural 1 6796 34 - - 50.03 33.26 66.80 
Study time 2009-2012 3 14370 1190 99.22 <0.001 1149.51 532.33 1766.69 8.651 0.003 
2013-2014 4 34533 575 99.58 <0.001 188.30 87.97 288.63 
Study site East of China 8 46187 1586 99.46 <0.001 494.32 362.42 626.23 0.286 0.593 
Central China 3 21134 617 99.45 <0.001 290.11 47.37 532.84 
Screening tools CABS 5 35580 1396 99.63 <0.001 422.06 219.60 624.51 0.524 0.769 
CAST 1 701 35 - 0.012 499.29 338.06 660.52 
CHAT 5 31040 772 99.33 <0.001 431.86 268.90 594.83 
Age (years) <=4 5 29158 1536 99.37 <0.001 530 260 1040 10.653 0.001 
>4 3 22428 192 96.93 <0.001 80 30 190 
            
Autism 22 223189 4467 99.60 <0.001 252.84 216.10 289.57 5245.70  
Gender Males 12 53265 2156 99.28 <0.001 377.25 264.79 354.82 0.924 0.336 
Females 12 46841 1120 98.53 <0.001 247.89 188.23 307.54 
Study time 1996-2006 6 42116 177 99.81 <0.001 39.17 11 71 19.013 <0.001 
2007-2014 9 70378 1503 99.91 <0.001 349.82 216.66 482.98 
Study site East of China 14 177279 3436 99.73 <0.001 260.11 213.92 306.29 2.241 0.524 
West of China 4 23942 262 97.49 <0.001 149.78 92.40 207.16 
Central China 3 21968 769 98.4 <0.001 334.73 151.68 517.78 
Screening tools ABC 4 46116 684 98.86 <0.001 136.67 44.47 228.87 0.791 0.673 
CABS 14 138768 3136 99.65 <0.001 268.94 213.49 324.39 
CHAT 4 38305 647 99.46 <0.001 406.73 115.76 697.70 
Age (years) ≤3.58 5 23170 794 98.77 <0.001 290 140  590 0.567 0.451 
＞3.58 4 51439 3018 99.54 <0.001 440 200 950 
Screen tools: ABC, Autism Behavior Checklist; CABS, Clancy Autism Behavior Scale; CARS, Childhood Autism Rating Scale; CHAT, Checklist for Autism in Toddlers; CAST, Children Autism Spectrum 
Test 
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Discussion 
This comprehensive meta-analysis of the pooled 
prevalence of ASDs and autism included 44 studies 
with 2,337,321 subjects in China covering 30 of the 34 
provinces/ municipalities/ autonomous regions of 
the country. The large variation in prevalence 
between studies is probably due to methodological 
differences in sampling methods and screening tools 
or diagnosis criteria used. This meta-analysis found 
that the pooled prevalence of ASD based on clinical 
diagnostic criteria was 39.23 per 10,000, which is 
lower than in other countries worldwide. For exam-
ple, Duchan et al. [14] found that the prevalence of 
ASDs was 60 per 10,000 in North America. In Europe, 
the median rate of ASD was 61.9 per 10,000 [15], while 
in the USA the prevalence of ASD was 110 per 10,000 
[16]. Further, in Asia the figure was 264 per 10,000 in 
South Korea [17] and 181 per 10,000 in Japan [18].  
On the other hand, the pooled prevalence of 
autism of 10.18 per 10,000 established by clinical 
diagnostic criteria was similar to the systemic review 
of 24 studies in China (12.8 per 10,000) [9] and another 
meta-analysis of 18 studies (11.8 per 10,000) [10]. 
Although significant heterogeneity 
between studies (I2=92.5%) was 
noted, sensitivity analyses did not 
find any outlying studies that 
significantly affect the overall results 
in each diagnostic group. 
Screening tools on ASDs and 
autism have been widely used in 
epidemiological surveys globally. 
Based on such screening tools, in this 
study the prevalence of ASDs 
ranged from 33 per 10,000 to 1853.3 
per 10,000 with the pooled figure of 
429.07 per 10,000, while the 
prevalence of autism ranged from 10 
per 10,000 to 1259.8 per 10,000 with 
the pooled figure of 252.84 per 
10,000. The CABS was the most 
commonly used screening tool for 
autism in China [19], but rarely used 
in Western studies. In contrast, the 
ADOS and Autism Diagnostic 
Interview- Revised (ADI-R) were 
widely used in Western studies. In 
addition, the ADOS and ADI-R 
included more information than the 
CABS. Thus, the discrepancy in 
screening tools used for ASDs and 
autism could partly explain the 
different findings between Chinese 
and Western studies [10]. 
Previous studies found that the 
prevalence of ASD and autism 
established by clinical diagnostic 
criteria in males was 3-4 times 
higher than in females [20, 21], 
which is consistent with the results 
of our study. We also found that the 
pooled prevalence of autism in 
urban areas was significantly higher 
than in rural areas, which is concor-
dant with the urban/rural rates in 
other developed countries, such as 
 
 
Figure 3. A) Forest plot of prevalence of autism spectrum disorders based on screening tools B) Forest 
plot of prevalence of autism based on screening tools 
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in the USA [22]. Various environmental stressors [23], 
such as prenatal exposure to environmental stress [24] 
and lower parental education [16] may partly lead to 
the urban/ rural difference. However, the urban 
/rural difference was not found in the prevalence of 
ASDs in this study. 
Children aged 2-6 years had the highest 
prevalence of ASDs in previous surveys. This study 
found that the age group ≤4 years had a higher 
prevalence (530 per 10,000) than the group > 4 years 
(80 per 10,000), which is not consistent with the 
findings (the highest risk in children aged 4–6 years) 
in a national survey in China [25]. In China children 
with ASDs are usually sent to special schools, which 
may result in an underestimated prevalence of ASDs 
in school age children in epidemiological surveys. 
Further, screening tools that have been widely used in 
China, such as the CABS, were originally designed to 
be completed by parents [26]. Parents may wish to 
avoid the diagnosis of autism or hoped that the 
symptoms would be reversed in their children, which 
may lead to an underestimation in self-reported 
surveys [7]. All these factors could contribute to the 
relatively lower prevalence of ASDs in school age 
groups [27]. 
The prevalence of autism based on clinical 
diagnostic criteria in studies done before the year 2008 
(8.18 per 10,000) was significantly lower than that 
after 2008 (20.4 per 10,000), which was consistent with 
previous findings [14]. However, the trend appeared 
to be the opposite in the prevalence of ASDs (38.72 per 
10,000 in and before 2012, and 36.36 per 10,000 after 
2012). The discrepancy in findings across study period 
may be related to differences in diagnostic criteria and 
qualification of interviewers. In addition, children 
with ASDs usually present with complex symptoms, 
which could lead to inaccurate diagnosis [28]. The 
improvement of standardized interview and 
diagnostic instruments could partly explain the 
increased prevalence of autism over time. 
The results need to be interpreted with caution 
due to several limitations. First, heterogeneity was 
present even in subgroup analyses although such 
heterogeneity is difficult to avoid in epidemiological 
studies [29]. Second, different screening instruments 
and diagnostic criteria were used across studies. In 
order to reduce the relevant heterogeneity, subgroup 
analyses between different screening instruments and 
diagnostic criteria were conducted. Third, the 44 
studies in this meta-analysis covered 30, but not all 
the 34 provinces/municipalities/autonomous regions 
in China. Finally, relevant factors on the prevalence of 
ASDs, such as socioeconomic and environmental 
variables, were not recorded in the majority of papers, 
therefore their impact could not be examined.  
In conclusion, the prevalence estimates of ASDs 
and autism are generally lower in China than in other 
countries worldwide. Further epidemiological studies 
with stringent methodology are needed to clarify the 
variation in prevalence. 
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